<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="40964">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02573103</url>
  </required_header>
  <id_info>
    <org_study_id>WHuang</org_study_id>
    <nct_id>NCT02573103</nct_id>
  </id_info>
  <brief_title>Air Pollution and Lipids Metabolic Disorder</brief_title>
  <official_title>Air Pollution and Lipids Metabolic Disorder</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>WeiHuang</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the effect of ambient PM2.5 exposures at &quot;low levels&quot; in Southeastern Michigan
      and &quot;high levels&quot; in beijing on lipid metabolism among healthy adults without CV disease.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">January 2016</completion_date>
  <primary_completion_date type="Actual">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Dyslipidemia</measure>
    <time_frame>One year</time_frame>
    <description>Analyzed HDL and LDL and TG by ultracentrifugation and HPLC</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>System inflammatory</measure>
    <time_frame>One year</time_frame>
    <description>Analyzed systemic inflammation biomarkers,such as C-reaction Protein and Blood coagulation by ELISA</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular endothelial function</measure>
    <time_frame>One year</time_frame>
    <description>Vascular endothelial function measured by EndoPat2000</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">75</enrollment>
  <condition>Lipids Metabolic Disorder</condition>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma and urine
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        We will maintain enrollment criteria of the in-progress study being 50 healthy adults
        without CV disease or risk factors
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  without CV disease or risk factors (e.g., hypertension, diabetes, or treated
             hyperlipidemia). Subjects are non-smokers in non-smoking household.

        Exclusion Criteria:

          -  Screening visit BP&gt;140/90 mm Hg, fasting glucose &gt;126 mg/dL, or positive urine
             pregnancy test (females). Subjects cannot be taking any medications or
             over-the-counter drugs that affect CV function.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wei Huang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University School of Public Health</affiliation>
  </overall_official>
  <verification_date>October 2015</verification_date>
  <lastchanged_date>April 3, 2016</lastchanged_date>
  <firstreceived_date>September 28, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Peking University</investigator_affiliation>
    <investigator_full_name>WeiHuang</investigator_full_name>
    <investigator_title>Peking University School of Public Health</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Metabolic Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
